In addition, dabigatran, apixaban, and rivaroxaban showed a trend toward higher rates of stroke or VTE with increasing inducer strength among the three groups (all p-values for trends <0.001) (Table 5 ).
← all excerpts
Stroke and Thrombotic Events Associated With Concomitant Use of Oral Anticoagulants and Antiepileptic Drugs in the United States and Japan.
1
—
—